EMPLICITI

Product NDC
0003-2291
11-digit product format
000032291
Labeler code
0003
Product ID
0003-2291_8441efc2-338a-4d1d-8fa1-9b9863a49ffd
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
elotuzumab
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Labeler
E.R. Squibb & Sons, L.L.C.
Application
BLA761035
Marketing category
BLA
Marketing start
2015-11-30
Substance
ELOTUZUMAB
Active strength
300 mg/1
Pharmacologic classes
Antibodies, Monoclonal [CS], SLAMF7-directed Antibody Interactions [MoA], SLAMF7-directed Immunostimulatory Antibody [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
EMPLICITI
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
ELOTUZUMAB300 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii1351PE5UGS
Rxcui1726110, 1726115, 1726117, 1726119

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c94a0353-f44d-461e-b70d-9389ff5e5602Product name120151215

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0003-2291-11EMPLICITI1 in 1 CARTONINJECTION, POWDER, LYOPHILIZED,113
0003-2291-11EMPLICITI1 in 1 VIAL, SINGLE-USEINJECTION, POWDER, LYOPHILIZED,113

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0003-2291-11EA - Each0003-22915e1e7a04-10f5-4e46-8f2f-835bd6cc119412016-01-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0003-2291EMPLICITI (ELOTUZUMAB) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [E.R. SQUIBB & SONS, L.L.C.]13Current NDC, Legacy NDC, 2 package rows20240628_80686b7e-f6f4-4154-b5c0-c846425e2d91.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1726110elotuzumab 300 MG InjectionPSN80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726117elotuzumab 400 MG InjectionPSN80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726115Empliciti 300 MG InjectionPSN80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726119Empliciti 400 MG InjectionPSN80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726115elotuzumab 300 MG Injection [Empliciti]SBD80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726119elotuzumab 400 MG Injection [Empliciti]SBD80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726110elotuzumab 300 MG InjectionSCD80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726117elotuzumab 400 MG InjectionSCD80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726115Empliciti 300 MG InjectionSY80686b7e-f6f4-4154-b5c0-c846425e2d9113
1726119Empliciti 400 MG InjectionSY80686b7e-f6f4-4154-b5c0-c846425e2d9113

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
0003-2291-11000032291111 VIAL, SINGLE-USE in 1 CARTON (0003-2291-11) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE2015-11-300000-00-00NoNoCurrent